BRIACELL THERAPEUTICS CORP. (BCTXL) Net income 2021–2026
BRIACELL THERAPEUTICS CORP. (BCTXL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$34.9MFY2026 · since FY2021: -$13.8M → -$34.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$34.9M | -32.7% |
| FY2025 | -$26.3M | -449.1% |
| FY2024 | -$4.8M | +76.4% |
| FY2023 | -$20.3M | +24.4% |
| FY2022 | -$26.8M | -94.3% |
| FY2021 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTXL financial trends
BCTXL RevenueBCTXL Net marginBCTXL Gross profitBCTXL Gross marginBCTXL Operating incomeBCTXL Operating marginBCTXL Operating cash flowBCTXL Free cash flowBCTXL Capital expendituresBCTXL Return on equityBCTXL Stock buybacksBCTXL Dividends paidBCTXL Total assetsBCTXL Total liabilitiesBCTXL Shareholders’ equityBCTXL overview →